Sanjivani Paranteral Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24300MH1994PLC081752 Incorporated 05 October 1994 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 531569 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹68.67 Cr
▼ 2.04% YoY
Computed EBITDA · FY 2026
₹11.4 Cr
▼ 1.43% YoY
Net profit · FY 2026
₹6.69 Cr
▼ 17.3% YoY
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹12.28 Cr
Issued & subscribed
Open charges
₹8 Cr
Satisfied ₹192.05 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
31
Latest available

About Sanjivani Paranteral Limited

Data last updated: 14 July 2026

Sanjivani Paranteral Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 05 October 1994, the company has been in operation for over 32 years.

Registered with ROC Mumbai under CIN L24300MH1994PLC081752. Listed on BSE: 531569.

Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹12.28 Cr. It is led by directors including Srivardhan Ashwani Khemka and Ashwani Anamisharan Khemka.

Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: 205 P – N Kothari Indl Estatel B S Marg Bhandup (W), Mumbai, Maharashtra, India – 400078.

As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹68.67 Cr, a decline of 2.04% compared to the previous year. The net worth stands at ₹50.84 Cr (up 27.51% YoY). Total assets are valued at ₹87.97 Cr (up 12.5% YoY).

The company has a workforce of approximately 31 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Sanjivani Parenteral. As per MCA filings, the company has open charges of ₹8 Cr and satisfied charges of ₹192.05 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanjivani.co.in.

Company Details of Sanjivani Paranteral Limited
CIN L24300MH1994PLC081752
Registration Number 081752
Incorporation Date 05 October 1994
ROC Mumbai
Listing Status Listed (BSE: 531569)
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    205 P – N Kothari Indl Estatel B S Marg Bhandup (W), Mumbai, Maharashtra, India – 400078
  • Industry
    Pharma, Drug Formulation & Development
Company report
Sanjivani Paranteral Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sanjivani Paranteral Limited report

Financials, compliance, directors, charges, ownership and filings for Sanjivani Paranteral Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Sanjivani Paranteral Limited

Sanjivani Paranteral Limited operates one associated brand: Sanjivani Parenteral. These brands represent Sanjivani Paranteral Limited's diversified market presence and brand portfolio.

Brand Description Website
Generic injectables, oral solids, and sterile powders are manufactured. sanjivani.co.in

Business Activity of Sanjivani Paranteral Limited

Sanjivani Paranteral Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Sanjivani Paranteral Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Sanjivani Paranteral Limited

Sanjivani Paranteral Limited is audited by M/s R B GOHIL & CO (ICAI peer reviewed, certificate valid till 2027-12-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
M/s R B GOHIL & CO (ICAI peer reviewed, certificate valid till 2027-12-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Sanjivani Paranteral Limited

Sanjivani Paranteral Limited is currently managed by 5 directors, with 12 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Srivardhan Ashwani Khemka Director 24 Mar 2022 4 Years 3 Months Current
Ashwani Anamisharan Khemka Managing Director 05 Oct 1994 31 Years 9 Months Current
Monika Amit Singhania Director 24 Mar 2022 4 Years 3 Months Current
Basant Shrivastava Additional Director 11 Sep 2025 0 Years 10 Months Current
Abhay Milan Shah Director 08 Apr 2024 2 Years 3 Months Current

Financials of Sanjivani Paranteral Limited FY 2026 filings available

Sanjivani Paranteral Limited reported revenue of ₹68.67 Cr (down 2.04% YoY) for FY 2026.

Revenue · FY 2026
₹68.67 Cr ▼ 2.04%
Profit · FY 2026
₹6.69 Cr ▼ 17.3%
Computed EBITDA · FY 2026
₹11.4 Cr ▼ 1.43%
Revenue₹ Cr · Consolidated0255075FY 2025: ₹70 Cr70.1FY 2025FY 2026: ₹69 Cr · -2% YoY68.7-2%FY 2026
Net Profit₹ Cr · Consolidated0510FY 2025: ₹8 Cr8.1FY 2025FY 2026: ₹7 Cr · -17.3% YoY6.7-17.3%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year0102030Q2'25: ₹18 Cr18.1Q2'25Q3'25: ₹17 Cr17.3Q3'25Q4'25: ₹18 Cr18.2Q4'25Q1'26: ₹18 Cr17.9Q1'26Q2'26: ₹18 Cr · +2% YoY18.5+2%Q2'26Q3'26: ₹22 Cr · +27.2% YoY22.1+27.2%Q3'26Q4'26: ₹13 Cr · -27.3% YoY13.2-27.3%Q4'26
Metrics FY 2026 FY 2025
Revenue from Operations ₹68.67 Cr ₹70.1 Cr
Other Income ₹1.09 Cr ₹1.22 Cr
Total Income ₹69.76 Cr ₹71.31 Cr
Cost of Materials Consumed ₹43.53 Cr ₹33.56 Cr
Purchases of Stock-in-Trade ₹0 ₹0
Changes in Inventories ₹4.53 Lakh ₹6.92 Cr
Employee Benefit Expense ₹7.01 Cr ₹6.49 Cr
Finance Costs ₹79.13 Lakh ₹59.27 Lakh
Depreciation & Amortisation ₹1.22 Cr ₹62.09 Lakh
Other Expenses ₹7.77 Cr ₹12.77 Cr
Total Expenses ₹60.36 Cr ₹60.96 Cr
Profit Before Exceptional Items & Tax ₹9.39 Cr ₹10.35 Cr
Exceptional Items ₹0 ₹0
Profit Before Tax ₹9.39 Cr ₹10.35 Cr
Total Tax Expense ₹2.7 Cr ₹2.26 Cr
Net Profit ₹6.69 Cr ₹8.09 Cr
Other Comprehensive Income ₹0 ₹0
Total Comprehensive Income ₹6.69 Cr ₹8.09 Cr
EBITDA (computed) ₹11.4 Cr ₹11.57 Cr
Basic EPS ₹5.49 ₹6.89
Diluted EPS ₹5.49 ₹6.66
Metrics FY 2026 FY 2025
Total Assets ₹87.97 Cr ₹78.2 Cr
Non-current Assets ₹51.57 Cr ₹44.02 Cr
Current Assets ₹36.4 Cr ₹34.18 Cr
Property, Plant & Equipment ₹46.92 Cr ₹20.56 Cr
Inventories ₹11.02 Cr ₹10.51 Cr
Trade Receivables ₹15.43 Cr ₹16.68 Cr
Cash & Equivalents ₹1.24 Cr ₹1.49 Cr
Equity (Net Worth) ₹50.84 Cr ₹39.87 Cr
Equity Share Capital ₹12.28 Cr ₹11.88 Cr
Borrowings (Non-current) ₹8.57 Cr ₹5.29 Cr
Borrowings (Current) ₹5.71 Cr ₹2.85 Cr
Total Debt (computed) ₹14.28 Cr ₹8.14 Cr
Current Liabilities ₹26.39 Cr ₹31.79 Cr
Total Liabilities ₹37.13 Cr ₹38.33 Cr
Metrics FY 2026 FY 2025
Operating Cash Flow ₹2.83 Lakh ₹12.4 Cr
Investing Cash Flow -₹9.97 Cr -₹20.11 Cr
Financing Cash Flow ₹9.7 Cr ₹8.66 Cr
Capital Expenditure ₹8.73 Cr ₹30.35 Cr
Free Cash Flow (computed) -₹8.7 Cr -₹17.95 Cr
Dividends Paid ₹61.42 Lakh ₹0
Net Change in Cash -₹24.22 Lakh ₹94.45 Lakh
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25
Revenue from Operations ₹13.21 Cr ₹22.06 Cr ₹18.5 Cr ₹17.89 Cr ₹18.18 Cr ₹17.35 Cr ₹18.13 Cr
Other Income ₹59.58 Lakh ₹29.51 Lakh ₹16.39 Lakh ₹3.59 Lakh ₹42.83 Lakh ₹31.18 Lakh ₹38.92 Lakh
Total Income ₹13.81 Cr ₹22.36 Cr ₹18.66 Cr ₹17.93 Cr ₹18.61 Cr ₹17.66 Cr ₹18.52 Cr
Cost of Materials Consumed ₹7.45 Cr ₹14.02 Cr ₹10.66 Cr ₹11.4 Cr ₹9.61 Cr ₹10.11 Cr ₹6.24 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹5.44 Lakh ₹71.46 Lakh -₹32.44 Lakh -₹29.05 Lakh -₹21.42 Lakh -₹18.49 Lakh ₹4.66 Cr
Employee Benefit Expense ₹2.24 Cr ₹1.76 Cr ₹1.49 Cr ₹1.52 Cr ₹2.11 Cr ₹1.65 Cr ₹1.61 Cr
Finance Costs ₹31.4 Lakh ₹20.86 Lakh ₹4.96 Lakh ₹21.91 Lakh ₹20.25 Lakh ₹19.39 Lakh ₹18.04 Lakh
Depreciation & Amortisation ₹65.69 Lakh ₹22.73 Lakh ₹16.85 Lakh ₹16.36 Lakh ₹18.39 Lakh ₹15.9 Lakh ₹14.55 Lakh
Other Expenses ₹2 Cr ₹1.73 Cr ₹1.42 Cr ₹2.61 Cr ₹4.07 Cr ₹3.22 Cr ₹2.76 Cr
Total Expenses ₹12.61 Cr ₹18.66 Cr ₹13.47 Cr ₹15.63 Cr ₹15.96 Cr ₹15.15 Cr ₹15.6 Cr
Profit Before Exceptional Items & Tax ₹1.2 Cr ₹3.7 Cr ₹5.19 Cr ₹2.3 Cr ₹2.65 Cr ₹2.51 Cr ₹2.92 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹1.2 Cr ₹3.7 Cr ₹5.19 Cr ₹2.3 Cr ₹2.65 Cr ₹2.51 Cr ₹2.92 Cr
Total Tax Expense ₹65.37 Lakh ₹92.19 Lakh ₹55.31 Lakh ₹57 Lakh ₹46.74 Lakh ₹61.07 Lakh ₹62 Lakh
Net Profit ₹54.85 Lakh ₹2.78 Cr ₹4.64 Cr ₹1.73 Cr ₹2.19 Cr ₹1.9 Cr ₹2.3 Cr
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹54.85 Lakh ₹2.78 Cr ₹4.64 Cr ₹1.73 Cr ₹2.19 Cr ₹1.9 Cr ₹2.3 Cr
EBITDA (computed) ₹2.17 Cr ₹4.13 Cr ₹5.41 Cr ₹2.68 Cr ₹3.04 Cr ₹2.86 Cr ₹3.24 Cr
Basic EPS ₹0.49 ₹2.21 ₹3.78 ₹1.46 ₹1.84 ₹1.62 ₹1.96
Diluted EPS ₹0.49 ₹2.21 ₹3.78 ₹1.41 ₹1.61 ₹1.62 ₹1.96
Latest 7 quarters shown.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹64.76 Cr ₹70.1 Cr ₹54.41 Cr ₹35.49 Cr ₹30.61 Cr ₹25.1 Cr ₹16.36 Cr ₹25.09 Cr
Other Income ₹1.24 Cr ₹1.21 Cr ₹51.72 Lakh ₹55.35 Lakh ₹24.33 Lakh ₹25.77 Lakh ₹25.19 Lakh ₹95.9 Lakh
Total Income ₹66 Cr ₹71.31 Cr ₹54.93 Cr ₹36.05 Cr ₹30.86 Cr ₹25.36 Cr ₹16.61 Cr ₹26.05 Cr
Cost of Materials Consumed ₹41.65 Cr ₹33.56 Cr ₹34.37 Cr ₹19.84 Cr ₹12.66 Cr ₹14.14 Cr ₹9.93 Cr ₹14.6 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹27.67 Lakh ₹6.92 Cr -₹5.89 Cr -₹1.28 Cr -₹35.34 Lakh ₹66.93 Lakh -₹85.96 Lakh ₹46.97 Lakh
Employee Benefit Expense ₹6.33 Cr ₹6.49 Cr ₹4.1 Cr ₹3.27 Cr ₹3.09 Cr ₹2.49 Cr ₹2.61 Cr ₹2.73 Cr
Finance Costs ₹53.93 Lakh ₹59.27 Lakh ₹25.35 Lakh ₹35.87 Lakh ₹21.32 Lakh ₹12.59 Lakh ₹65.61 Lakh ₹32.84 Lakh
Depreciation & Amortisation ₹86.43 Lakh ₹62.09 Lakh ₹93.32 Lakh ₹88.77 Lakh ₹87.74 Lakh ₹85.98 Lakh ₹1.07 Cr ₹1.17 Cr
Other Expenses ₹7.11 Cr ₹12.76 Cr ₹13.59 Cr ₹8.02 Cr ₹9.5 Cr ₹5.66 Cr ₹5.01 Cr ₹9.04 Cr
Total Expenses ₹56.77 Cr ₹60.95 Cr ₹47.36 Cr ₹31.1 Cr ₹25.98 Cr ₹23.95 Cr ₹18.42 Cr ₹28.35 Cr
Profit Before Exceptional Items & Tax ₹9.23 Cr ₹10.36 Cr ₹7.57 Cr ₹4.94 Cr ₹4.88 Cr ₹1.41 Cr -₹1.81 Cr -₹2.3 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹9.23 Cr ₹10.36 Cr ₹7.57 Cr ₹4.94 Cr ₹4.88 Cr ₹1.41 Cr -₹1.81 Cr -₹2.3 Cr
Total Tax Expense ₹2.31 Cr ₹2.26 Cr ₹1.41 Cr ₹43.28 Lakh ₹3.22 Lakh -₹71,000 -₹10.03 Lakh -₹22.96 Lakh
Net Profit ₹6.92 Cr ₹8.1 Cr ₹6.17 Cr ₹4.51 Cr ₹4.85 Cr ₹1.42 Cr -₹1.71 Cr -₹2.07 Cr
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹6.92 Cr ₹8.1 Cr ₹6.17 Cr ₹4.51 Cr ₹4.85 Cr ₹1.42 Cr -₹1.71 Cr -₹2.07 Cr
EBITDA (computed) ₹10.63 Cr ₹11.57 Cr ₹8.76 Cr ₹6.19 Cr ₹5.97 Cr ₹2.4 Cr -₹8.03 Lakh -₹79.74 Lakh
Basic EPS ₹5.67 ₹6.89 ₹5.28 ₹4.51 ₹4.85 ₹1.67 ₹-2.90 ₹-3.50
Diluted EPS ₹5.67 ₹6.67 ₹5.28 ₹4.51 ₹4.85 ₹1.67 ₹-2.90 ₹-3.50
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹78.43 Cr ₹65 Cr ₹43.41 Cr ₹21.01 Cr ₹18.3 Cr ₹19.28 Cr ₹15.66 Cr ₹17.97 Cr
Non-current Assets ₹30.15 Cr ₹26.89 Cr ₹14.77 Cr ₹12.74 Cr ₹10.57 Cr ₹10.09 Cr ₹11.87 Cr ₹10.91 Cr
Current Assets ₹48.28 Cr ₹38.1 Cr ₹28.64 Cr ₹8.27 Cr ₹7.73 Cr ₹9.18 Cr ₹3.79 Cr ₹7.06 Cr
Property, Plant & Equipment ₹22.05 Cr ₹20.56 Cr ₹9.94 Cr ₹7.57 Cr ₹7.42 Cr ₹7.62 Cr ₹8.04 Cr ₹8.99 Cr
Inventories ₹9.54 Cr ₹10.42 Cr ₹9.73 Cr ₹5.35 Cr ₹1.75 Cr ₹91.41 Lakh ₹1.66 Cr ₹56.29 Lakh
Trade Receivables ₹11.01 Cr ₹16.68 Cr ₹4.7 Cr ₹1.99 Cr ₹4.92 Cr ₹6.63 Cr ₹1.07 Cr ₹5.21 Cr
Cash & Equivalents ₹1.15 Cr ₹63.34 Lakh ₹54.08 Lakh ₹30.25 Lakh ₹33.93 Lakh ₹17.42 Lakh ₹26.57 Lakh ₹23.37 Lakh
Equity (Net Worth) ₹48.39 Cr ₹38 Cr ₹27.9 Cr -₹3.07 Cr -₹7.58 Cr -₹44.89 Cr -₹48.91 Cr -₹47.2 Cr
Equity Share Capital ₹12.28 Cr ₹11.88 Cr ₹11.68 Cr ₹10 Cr ₹10 Cr ₹8.5 Cr ₹5.9 Cr ₹5.9 Cr
Borrowings (Non-current) ₹6.67 Cr ₹5.29 Cr ₹96.91 Lakh ₹75.95 Lakh ₹2.75 Cr ₹5.3 Cr ₹7.95 Cr ₹8.13 Cr
Borrowings (Current) ₹2.48 Cr ₹33.61 Lakh ₹0 ₹1.73 Cr ₹0 ₹36.6 Cr ₹26.92 Cr ₹26.92 Cr
Total Debt (computed) ₹9.15 Cr ₹5.62 Cr ₹96.91 Lakh ₹2.49 Cr ₹2.75 Cr ₹41.9 Cr ₹34.87 Cr ₹35.05 Cr
Current Liabilities ₹21.58 Cr ₹20.46 Cr ₹13.78 Cr ₹22.65 Cr ₹21.89 Cr ₹57.63 Cr ₹55.4 Cr ₹55.67 Cr
Total Liabilities ₹30.04 Cr ₹27 Cr ₹15.51 Cr ₹24.08 Cr ₹25.88 Cr ₹64.17 Cr ₹64.57 Cr ₹65.18 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹1.55 Cr -₹23.86 Lakh -₹10.7 Cr ₹4.73 Cr ₹8.52 Cr
Investing Cash Flow -₹4.47 Cr -₹5.81 Cr -₹12.21 Cr -₹1.04 Cr -₹67.33 Lakh
Financing Cash Flow ₹6.54 Cr ₹6.14 Cr ₹23.16 Cr -₹3.73 Cr -₹7.68 Cr
Capital Expenditure ₹2.62 Cr ₹11.24 Cr ₹3.3 Cr ₹1.1 Cr ₹68.35 Lakh
Free Cash Flow (computed) -₹4.17 Cr -₹11.48 Cr -₹14.01 Cr ₹3.63 Cr ₹7.84 Cr
Dividends Paid ₹61.42 Lakh ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹51.64 Lakh ₹9.26 Lakh ₹23.83 Lakh -₹3.68 Lakh ₹16.51 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹10.51 Cr ₹20.86 Cr ₹15.5 Cr ₹17.89 Cr ₹18.18 Cr ₹17.35 Cr ₹18.13 Cr ₹16.44 Cr
Other Income ₹74.69 Lakh ₹29.05 Lakh ₹16.39 Lakh ₹3.59 Lakh ₹42.68 Lakh ₹31.18 Lakh ₹38.92 Lakh ₹8.57 Lakh
Total Income ₹11.26 Cr ₹21.15 Cr ₹15.66 Cr ₹17.93 Cr ₹18.61 Cr ₹17.66 Cr ₹18.52 Cr ₹16.52 Cr
Cost of Materials Consumed ₹6.17 Cr ₹13.41 Cr ₹10.66 Cr ₹11.4 Cr ₹9.61 Cr ₹10.11 Cr ₹6.24 Cr ₹7.6 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹11.71 Lakh ₹77.45 Lakh -₹32.44 Lakh -₹29.05 Lakh -₹21.42 Lakh -₹18.49 Lakh ₹4.66 Cr ₹2.66 Cr
Employee Benefit Expense ₹1.69 Cr ₹1.62 Cr ₹1.49 Cr ₹1.52 Cr ₹2.11 Cr ₹1.65 Cr ₹1.61 Cr ₹1.13 Cr
Finance Costs ₹6.2 Lakh ₹20.86 Lakh ₹4.96 Lakh ₹21.91 Lakh ₹20.25 Lakh ₹19.39 Lakh ₹18.04 Lakh ₹1.59 Lakh
Depreciation & Amortisation ₹34.54 Lakh ₹18.68 Lakh ₹16.85 Lakh ₹16.36 Lakh ₹18.39 Lakh ₹15.9 Lakh ₹14.55 Lakh ₹13.25 Lakh
Other Expenses ₹1.62 Cr ₹1.46 Cr ₹1.42 Cr ₹2.61 Cr ₹4.06 Cr ₹3.22 Cr ₹2.76 Cr ₹2.71 Cr
Total Expenses ₹10.01 Cr ₹17.67 Cr ₹13.47 Cr ₹15.63 Cr ₹15.95 Cr ₹15.15 Cr ₹15.6 Cr ₹14.25 Cr
Profit Before Exceptional Items & Tax ₹1.25 Cr ₹3.49 Cr ₹2.19 Cr ₹2.3 Cr ₹2.66 Cr ₹2.51 Cr ₹2.92 Cr ₹2.27 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹1.25 Cr ₹3.49 Cr ₹2.19 Cr ₹2.3 Cr ₹2.66 Cr ₹2.51 Cr ₹2.92 Cr ₹2.27 Cr
Total Tax Expense ₹31.31 Lakh ₹87.19 Lakh ₹55.31 Lakh ₹57 Lakh ₹46.74 Lakh ₹61.07 Lakh ₹62 Lakh ₹56 Lakh
Net Profit ₹93.74 Lakh ₹2.62 Cr ₹1.64 Cr ₹1.73 Cr ₹2.19 Cr ₹1.9 Cr ₹2.3 Cr ₹1.71 Cr
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹93.74 Lakh ₹2.62 Cr ₹1.64 Cr ₹1.73 Cr ₹2.19 Cr ₹1.9 Cr ₹2.3 Cr ₹1.71 Cr
EBITDA (computed) ₹1.66 Cr ₹3.88 Cr ₹2.41 Cr ₹2.68 Cr ₹3.05 Cr ₹2.86 Cr ₹3.24 Cr ₹2.42 Cr
Basic EPS ₹0.80 ₹2.13 ₹1.33 ₹1.46 ₹1.84 ₹1.62 ₹1.96 ₹0.00
Diluted EPS ₹0.80 ₹2.13 ₹1.33 ₹1.41 ₹1.62 ₹1.62 ₹1.96 ₹0.00
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Sanjivani Paranteral Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Sanjivani Paranteral Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 31.26%, domestic institutional investors hold 6.04%, retail and other public shareholders hold 62.71% of Sanjivani Paranteral Limited. The company had 5,933 shareholders on record.

Promoters: 31.26%DII (Domestic Institutional): 6.04%Retail & Others: 62.71%
Mar 2026
QUARTER
31.26% Promoters
6.04% DII (Domestic Institutional)
62.71% Retail & Others
Promoter holding - history
Now 31.26% · Mar 2026High 32.34% · Sep 2023Low 27.67% · Mar 2024
26%28%30%32%34%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 31.70%Sep 2023: 32.34%Dec 2023: 32.34%Mar 2024: 27.67%Jun 2024: 27.67%Sep 2024: 27.67%Dec 2024: 27.67%Mar 2025: 28.87%Jun 2025: 28.87%Sep 2025: 31.20%Dec 2025: 31.20%Mar 2026: 31.26%32.34%27.67%31.26%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters31.26%31.20%31.20%28.87%28.87%27.67%
Public68.74%68.80%68.80%71.13%71.13%72.33%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters31.26%28.87%27.67%
Public68.74%71.13%72.33%
Promoter change (YoY, %pts)+2.39+1.20-

Group Structure of Sanjivani Paranteral Limited

Sanjivani Paranteral Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Sanjivani Paranteral Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Spl Infusion Private Limited U21001MH2024PTC419970 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Sanjivani Paranteral Limited

Open charges
₹8 Cr
Satisfied charges
₹192.05 Cr
Breakdown by lending institutions
Others₹8.00 Cr
Latest charge details
DateLenderAmountStatus
21 Nov 2025 Others ₹1 Cr Open
25 Mar 2025 Others ₹1.5 Cr Open
14 Aug 2024 Others ₹50 Lakh Open
31 Jul 2024 Others ₹5 Cr Open
26 Jun 2015 Others ₹4 Cr Satisfied

Total charge records: 29 View all charges

Employees and EPFO Compliance at Sanjivani Paranteral Limited

Sanjivani Paranteral Limited has a workforce of 31 employees as of Mar 25, 2025.

Employee count
31
Active EPFO establishments
2
Employee growth
-13.89%
Premium access

Employee and EPFO history for Sanjivani Paranteral Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Sanjivani Paranteral Limited

Premium access

GST registrations and filing compliance for Sanjivani Paranteral Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Sanjivani Paranteral Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Sanjivani Paranteral Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sanjivani Paranteral Limited

Premium access

MSME payment history for Sanjivani Paranteral Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Sanjivani Paranteral Limited

Premium access

Corporate group structure for Sanjivani Paranteral Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sanjivani Paranteral Limited

Premium access

MCA filings and documents for Sanjivani Paranteral Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Sanjivani Paranteral Limited

Charges
21 Nov 2025
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 101196027 was registered on 21 Nov 2025.
Activity
26 Sep 2025
Sanjivani Paranteral Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Directors
11 Sep 2025
Basant Shrivastava was appointed as a Additional Director on 11 Sep 2025 & has been associated with this company since 10 months 9 days.
Activity
31 Mar 2025
Sanjivani Paranteral Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
25 Mar 2025
A charge with Others amounted to Rs. 1.50 Cr with Charge ID 101078067 was registered on 25 Mar 2025.
Directors
31 Aug 2024
Ravikumar Venkatramuloo Bogam was appointed as a Company Secretary on 31 Aug 2024 & has been associated with this company since 1 year 10 months.

Recent News on Sanjivani Paranteral Limited

Sanjivani Paranteral raises funds worth Rs 30.88 Cr
27 Dec 2023 · BioSpectrum India

Frequently Asked Questions about Sanjivani Paranteral Limited

Sanjivani Paranteral Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 05 October 1994 (32+ years old) and is registered under CIN L24300MH1994PLC081752. Listed on BSE: 531569. The company has 31 employees.

Sanjivani Paranteral Limited reported revenue of ₹68.67 Cr for FY 2026 (down 2.04% YoY) based on consolidated BSE filings.

The current directors of Sanjivani Paranteral Limited are:

The primary industry of Sanjivani Paranteral Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Sanjivani Paranteral Limited is listed on BSE with code 531569.

Sanjivani Paranteral Limited can be reached at the registered office: 205 P – N Kothari Indl Estatel B S Marg Bhandup W, Mumbai, Maharashtra, India – 400078, or through the website sanjivani.co.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available